GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis
US-11352405-B2 · Jun 7, 2022 · US
This page is not indexed by search engines while we improve data quality.
Haack Torsten patents
Haack Torsten is listed as an inventor on 39 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Haack Torsten |
| Total patents | 39 |
| First publication | Jun 18, 2015 |
| Latest publication | Jun 7, 2022 |
Notable patents
Publications ranked by popularity score, then publication date.
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate
US-10806797-B2 · Oct 20, 2020 · US
Exendin-4 derivatives as dual GLP1/glucagon agonists
US-10758592-B2 · Sep 1, 2020 · US
Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes
US-2020262885-A1 · Aug 20, 2020 · US
Glp-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis
US-2020216510-A1 · Jul 9, 2020 · US
Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists
US-10538567-B2 · Jan 21, 2020 · US
Compounds as peptidic GLP1/glucagon/GIP receptor agonists
US-10519211-B2 · Dec 31, 2019 · US
Functionalized Exendin-4 derivatives
US-10253079-B2 · Apr 9, 2019 · US
Prodrugs comprising an glp-1/glucagon dual agonist linker hyaluronic acid conjugate
US-2018289822-A1 · Oct 11, 2018 · US
Exendin-4 derivatives as dual glp1/glucagon agonists
US-2018185450-A1 · Jul 5, 2018 · US
Recent patents
Latest publications not already listed above.
Compounds as peptidic trigonal glp1/glucagon/gip receptor agonists
US-2018155406-A1 · Jun 7, 2018 · US
Compounds as peptidic glp1/glucagon/gip receptor agonists
US-2018155407-A1 · Jun 7, 2018 · US
Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists
US-9982029-B2 · May 29, 2018 · US
Exendin-4 derivatives as selective glucagon receptor agonists
US-9932381-B2 · Apr 3, 2018 · US
Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists
US-9789165-B2 · Oct 17, 2017 · US
Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists
US-9775904-B2 · Oct 3, 2017 · US
Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4
US-9771406-B2 · Sep 26, 2017 · US
Dual GLP-1/glucagon receptor agonists derived from exendin-4
US-9758561-B2 · Sep 12, 2017 · US
Non-acylated exendin-4 peptide analogues
US-9750788-B2 · Sep 5, 2017 · US
Dual GLP-1/GIP receptor agonists
US-9751926-B2 · Sep 5, 2017 · US
Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists
US-9745360-B2 · Aug 29, 2017 · US
Functionalized exendin-4 derivatives
US-2017216406-A1 · Aug 3, 2017 · US
Dual GLP-1/glucagon receptor agonists
US-9694053-B2 · Jul 4, 2017 · US
Functionalized exendin-4 derivatives
US-9670261-B2 · Jun 6, 2017 · US
Exendin-4 peptide analogues as dual glp-1/glucagon receptor agonists
US-2017022260-A9 · Jan 26, 2017 · US
Exendin-4 Derivatives as Selective Peptidic Dual GLP-1/Glucagon Receptor Agonists
US-2017008944-A1 · Jan 12, 2017 · US
Exendin-4 derivatives as dual glp1/glucagon agonists
US-2016220643-A1 · Aug 4, 2016 · US
Exendin-4 peptide analogues as dual glp-1/glucagon receptor agonists
US-2016168225-A1 · Jun 16, 2016 · US
Exendin-4 derivatives as dual GLP1/glucagon agonists
US-9365632-B2 · Jun 14, 2016 · US
Exendin-4 Derivatives as Selective Glucagon Receptor Agonists
US-2015368311-A1 · Dec 24, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Sanofi Sa | 39 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P3/10 | 39 |
| A61K45/06 | 36 |
| C07K14/605 | 34 |
| A61P3/04 | 32 |
| A61K38/26 | 32 |